Krystal Biotech Announces FDA Approval of Updated VYJUVEK Label

GlobeNewswire

Image Credit: GlobeNewswire

Please find more details at GlobeNewswire

Summary

Revised label allows treatment of DEB patients from birth VYJUVEK can now be applied by patients and caregivers PITTSBURGH, Sept. 15, 2025 ……

Source: GlobeNewswire

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!